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THE ZIRCONIUM DEODORANT GRANULOMA: 
AN ALLERGIC DISORDER* 
HARRY J. HURLEY, JR., M.D., D.SC. (Med.) ** AND WALTER B. SHELLEY, M.D., Ph D.** 
Within the last few years, a new and unusual disorder has been described in the 
dermatologic literature. This disease showed striking uniformity both clinically and 
histologically'''-^''*'''', although it was given a variety of names, including axiflary 
granulomas, sarcoid-like eruption of the axillae, granulomatous reaction to deodorant 
sticks, granulomas of the axillae caused by deodorants, and zirconium granulomas. 
It was characterized by the presence of persistent painless papules, with minimal acute 
inflammation and pruritus, appearing in the axillae of persons who had used zirconium-
containing deodorants (Figure 1). Histologically, a distinctive granulomatous reaction 
was seen and was diagnostic (Figure 2). This eruption proved to be virtually refractory 
to all forms of treatment and its course, following cessation of the deodorant, was one 
of very gradual, spontaneous involution. 
Figure 1 
Clinical appearance of axillary zirconium deodorant granulomas. 
This patient, a 36-year-old white housewife, developed numerous red-brown papules in the axillae a 
few months after daily application of a zirconium stick deodorant. Despite cessation of the deodorant 
the lesions persisted for over two years. 
*Presented before the Henry Ford Hospital Medical Society, April 8, 1958. 
'•Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Penn. 
This work was supported in part by a research grant (RG-4232 C3) from the Division of Research 
Grants, National Institutes of Health, United States Public Health Service. 
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Figure 2 
Biopsy of one of the axillary lesions shown in Figure 1 revealed characteristic sarcoid-type of granu-
lomatous patterning. In the upper photograph a low power (x70) microscopic view of the lesion 
shows nests of epithelioid cells replacing much of the normal dermis. In the lower photograph under 
higher power (x250) the cytologic appearance of the granulomatous infiltrate is visualized. A giant 
cell of the so-called Langhan's variety is evident in the upper right hand corner. 
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Great interest was evinced in this disorder and, in less than two years (1956 to 
1958), some 70 cases were described in the literature and a variety of speculations 
made as to its etiology. Prominent among these were foreign body reactions to 
zirconium''^ to contaminant metals such as beryllium' or hafnium', to the lipid'''", or 
other inert ingredients of the deodorant vehicle", and secondary apocrine sweat extra-
vasation'^ or follicular wall degeneration'^ However, there was little or no experimental 
support for any of these possibflities, and neither the incitant or incitants nor the 
mechanism by which the disease was produced were identified. 
In this paper we should like to review our experimental and clinical studies of 
this distinctive new dermatosis. We have elected to call this new condition the zirconium 
deodorant granuloma. As a result of these observations, we have concluded that the 
axfllary granulomas that develop incident to the use of zirconium deodorants are the 
result of a specific allergic hypersensitivity to the metal zirconium which manifests 
itself as a stable, sarcoid-like granuloma. 
The Zirconium Deodorant Stick 
I t should be emphasized that no single deodorant preparation had been used 
by all of the patients described in the literature. However, the vast majority had 
applied a new stick-type deodorant containing sodium zirconium lactate. This stick 
was essentially a soap-alcohol-gel composed of sodium stearate, ethyl alcohol, carbitol 
and water with approximately 10% of an aqueous solution of sodium zirconium 
lactate, and small amounts of hexachlorophene and a perfume incorporated into the 
basic gel. 
Each of the components of this stick alone or in combination was suspect in 
the production of this granulomatous disorder. However, it was difficult to predict 
which of these substances was causal. The sodium stearate seemed a quite unlikely 
candidate since the daily use of soap for years by many milllions of people on broken 
and unbroken skin has never produced a single granuloma. Similarly the ethyl 
alcohol, while at times capable of producing transient irritation, has never been known 
to induce such chronic change despite its ubiquity in cosmetic and topical medicinal 
products. Carbitol/diethylene glycol mono-ethyl (ether) as a congener of glycerine 
is miscible with water and extensive studies have indicated that it is essentially non-
irritating to rabbit skin'^. However, absorption of large amounts of carbitol can prove 
fatal to these animals. Hexachlorophene has been used for many years as a germicide 
for surgical scrubs. It has also been employed topically in creams and lotions on adult 
and infant skin without ill effect. The very small quantities of perfume that were 
present in the stick would seem to make it an unlikely possibility also. 
Of all the ingredients of the stick deodorant, zirconium loomed as the most logical 
canidate for the granulomagenic agent. Indeed, the majority of observers were of 
the opinion that it was in some way responsible, since the appearance of this new 
granuloma coincided with the introduction of zirconium in deodorants. Zirconium, 
a metaflic element in group IV period V of the periodic table, is normally found in 
the earth's crust as an oxide or siflcate in a concentration of about 0.22%. I t is 
not radio-active and is closely related to hafnium chemically. Actually, as much as 
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2% hafnium has been found in the purest zirconium preparations. Sodium zirconium 
lactate is a recently synthesized salt. It is used as a 40-45% aqueous solution (Ph-
7.5-8.2) which is compatible with soap. In the axilla its primary action is as a 
deodorant and it produces this effect apparently by reducing the surface bacterial 
flora and probably also by forming a complex with the malodorous fatty acids. Any 
antiperspirant effect fl may achieve is the result of eccrine poral closure in a manner 
similar to that of the aluminum salts. However, in the axilla this effect is not 
remarkable. 
Zirconium has long been regarded as a very inocuous substance. Careful toxi-
cologic studies support this'''"'". As a metal fl has been employed successfully in 
surgery as bone screws, cranial plates, intrameduflary pins, sutures, and bone clips". 
In animals its introduction in both soluble and insolube forms parenterally, by ingestion 
and by inhalation for as long as two years has not produced significant acute or 
chronic change"'20.2i,22. Granulomas have not been reported in men working with 
zirconium in industry nor have pulmonary changes been observed. Its use topically 
(4% zirconium dioxide ointment) in patients with poison ivy dermatitis has not 
proved harmful"'". Even intravenous administration of zirconium salts has been 
safely employed in patients wflh pyodermas". The consensus of opinion was that 
zirconium in any form seemed to be a safe and essentially harmlesss compound for 
man. Thus, despite the circumstantial evidence incriminating zirconium as the granu-
lomagenic substance, there was little in the literature to support such suspicion. 
Moreover, it should be pointed out that the new stick-type vehicle used in these 
deodorants was of very recent vintage also, and this lent credence to the view that 
one of the components of this stick or a contaminant was responsible. It thus became 
apparent that only through careful experimental study could one identify the substance 
or substances responsible for this new dermatosis. 
Experimental Studies 
I t was stated earlier that as a result of extensive experimental investigation we 
concluded that the zirconium deodorant granulomas were the result of an allergic 
hypersensitivity of these patients to the metal zirconium. These studies have been 
carefully detailed in another report". They were carried out under controlled conditions 
in healthy adult male volunteers. They may be summarized briefly as follows: 
(1) Experimental production of histologically proved axillary granulomas identical 
with those of clinical cases was achieved in two (subject No. 2 and subject No. 35) 
of f i f ty subjects by the daily intensive (5 minutes) application to the axillae of 
deodorant sticks containing sodium zirconium lactate in both 5 and 10% concen-
trations. Sticks containing zirconium in 1% concentration produced no such reaction. 
These granulomas were typically chronic persisting for as long as six months following 
cessation of the zirconium deodorant sticks. Several other subjects developed transitory 
acute inflammatory changes to the 5 and 10% zirconium sticks, but these reactions 
were cleariy non-granulomatous histologically. Control sticks, identical except for 
the absence of zirconium, failed to produce any acute inflammation or granuloma in 
any of the fifty subjects. 
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(2) Zirconium deodorant sticks deleted of the hexachlorophene, carbitol, and 
perfume regularly found in the commerciafly available sticks, were equally capable 
of inducing the granulomatous reaction. 
(3) Substitution of 5% aluminum chloride for the sodium zirconium lactate in 
the deodorant sticks failed to result in the development of axiflary granulomas. 
(4) There was no epidermal (contact) sensitivity to zirconium or any of the 
other ingredients of the deodorant stick as evidenced by routinely negative patch tests 
to the deodorant sticks in afl of the experimental .subjects. 
(5) Intradermal injections of dilutions of aqueous solutions of zirconium salts 
reproduced the granulomatous reaction in the two subjects (No. 2 and No. 35) in 
whom the axillary granulomas were seen to develop. Injection of these zirconium 
salts in many normal control subjects and injection of all other ingredients of the 
deodorant stick, as well as other representative metals (beryllium and sflicon) in 
subjects No. 2 and No. 35, and in the control subjects, failed to produce any such 
response. Table I depicts the results of these studies. 
(6) In a concentration of 1:10,000 aqueous solutions of soluble salts of fifty-
seven elements of the periodic table also were injected intradermally in the subjects 
No. 2 and No. 35, and in the twenty control subjects. In all of the men so treated 
there were no granulomatous reactions at any of the injection sites except at that 
of zirconium in subjects No. 35. It is to be recalled that he responded simflarly to 
1:10,000 zirconium in the previous series of injections (Table I ) . The elements that 
were included in this second series of intradermal tests included: 
Aluminum Europium Manganese Silicon 
Antimony Fluorine Mercury Silver 
Arsenic Gadolinium Molybdenum Strontium 
Barium Gallium Neobium Tantalum 
Beryllium Germanium Neodymium Tellurium 
Boron Hafnium Nickel Terbium 
Bromine Holmium Palladium Thulium 
Cadmium Indium Praesodymium Tin 
Cerium Iodine Rhenium Titanium 
Cesium Iridium Rhodium Tungsten 
Chromium Lanthanum Rubidium Vanadium 
Cobafl Lead Ruthenium Ytterbium 
Dysprosium Lflhium Samarium Yttrium 
Erbium Lutetium Scandium Zinc 
Zirconium 
These experimental studies indicated that zirconium and zirconium alone was 
the critical substance responsible for the development of the granulomatous reactions 
seen in this disorder. Furthermore, the pathogenesis of these granulomas was shown 
to be the result of a specific hypersensitivity, probably allergic in nature, to the 
metal zirconium. 
Our next step was to confirm these findings in clinical patients with the zirconium 
deodorant granulomas. 
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Table I 
to 
Intradermal 
Injections Sodium Zirconium Lactate 
Zirconium 
Chloride 
Zirconium 
Nitrate 
Beryllium 
Sulphate 
Colloidal 
Silica 
Other 
Compon-
ents of 
Deodorant 
Stick* 
(0.02 cc) 1 : 1(10 1:1000 1:10,000 1:100,000 1 :l()O0 1:10,000 1:1000 1:10,000 1:1000 1:1000 1:1000 
Subject No. 2 + -1- 0 0 + 0 -1- 0 0 0 0 
Subject No. 35 + + + 0 + + + + 0 0 0 
Controls (20) 0 0 0 0 0 0 0 0 0 0 0 
3: 
3 
a. 
=^  
— 
*The various ingredients of the stick were injected alone and in combination in the above concen-
trations. They included sodium stearate, hexachlorophene, ethyl alcohol, carbitol, and perfume. 
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Clinical Studies 
Four patients wflh zirconium deodorant granulomas were available for study. 
All had the typical histologically proved granulomatous lesions in the axillae and all 
were in good health. A battery of general medical studies were within normal limits 
on all of these patients. These patients were women, ranging in age from 23 to 42 
years. Three of the four women had used the zirconium stick deodorant for at least 
two months prior to the appearance of the eruption. However, one patient states 
that the lesions appeared after only two applications of the stick. In each case all 
forms of treatment, including topical steroids, were ineffective. The chronicity of 
the lesions was an outstanding feature in these patients, and in one patient residual 
papules were stifl visible over two years after cessation of the zirconium stick and 
other deodorant applications. 
Special studies performed on these patients included: 
(1) Intradermal injection (0.02 cc.) of 1:1000 and 1:10,000 dilutions of aqueous 
sodium zirconium lactate solution produced a papule in 10 days in three of the four 
patients. On biopsy these papules showed the characterstic granulomatous picture. 
The fourth patient responded similarly only to the 1:1000 dilution of the zirconium 
solution. None of the four patients showed any visible response to 1:100,000 sodium 
zirconium lactate. 
(2) Intradermal injections (0.02 cc.) of 1:1000 beryllium sulfate and 1:1000 
silicon dioxide were negative in all four patients. Patch tests to zirconium deodorant 
stick (full strength) were negative at 72 hours in all four subjects. However, in one 
subject, a small papule (Figure 3) appeared at about one month. Although involuting 
WmaBB 
Figure 3 
Granulomatous reaction appearing al site of patch test to zirconium stick deodorant. Four to five 
weeks after a negative response (72 hours) to a closed patch test to a standard zirconium stick 
deodorant, a papule (shown above) appeared in the patch test site in one of our clinical patients. 
Histologically this papule showed granulomatous change comparable to that seen in the axillary 
granulomas. 
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gradually, it was still evident six months later. This lesion was simflar clinically to the 
axillary granulomas and proved to be granulomatous histologically also. 
Discussion 
The metals, silicon and beryflium, have long been known to be capable of 
inducing cutaneous granulomas in some individuals after accidental inoculation"'''. 
In order to determine the presence or absence of these metals as contaminants, we had 
spectrographic analyses performed on the commercial sodium zirconium lactate solu-
tion used in our studies. Many elements were tested for and several were found to 
be present, in addition to the major constituent, zirconium. Silicon was detected in 
a concentration of about 0.008%, but beryllium was not found. Al l of the other 
elements found were in similariy low concentration and included aluminum, boron, 
calcium, chromium, iron, magnesium, nickel, and strontium. These were included in 
the test series of injections made on the experimental subjects, it should be recalled, 
and were found to be incapable of elicfling a granulomatous reaction. 
Although a perusal of these studies leaves little doubt that these patients mani-
fested a hypersensitivity to zirconium, that this hypersensitivity was allergic in nature 
requires further amplification. 
Allergic states are acquired, not inherited. Although we have no skin tests or 
other information indicating the lack of allergic hypersensitivity of these individuals 
prior to their exposure to the zirconium deodorant sticks, we may presume that they 
had no such prior hypersensitivity. This hypersensitivity developed some time during 
the period of application of the deodorant sticks. More compelling evidence that this 
zirconium hypersensitivity is acquired is avaflable in another experimental subject (not 
recorded here and not a part of these studies) in whom initially negative intradermal 
injections of zirconium became granulomatous several months later. Careful study of 
this subject verified the specific hypersensitivity to zirconium. 
Allergic states are specific. The specificity of the reactivity of these subjects to 
zirconium should be apparent after a review of the data outlined above. Moreover, 
the abflity to respond to great dilutions of the zirconium points to the allergic nature 
of this unusual reaction. 
Demonstration of an antigen-antibody reaction is an important and ultimately 
requisite step in the confirmation of allergic reactions. We are studying this problem 
at the moment. Classical serological tests and serum passive transfer techniques for 
the demonstration of antibody have not been of value possibly because the antibody 
concerned with this form of allergy may well be cellular. Modified cell transfer 
methods and other in vivo and in vitro methods are being employed at present. 
The failure to identify the antibody concerned with the hypersensitivity reaction 
to zirconium in the cases described herein does not invalidate our thesis that this 
reaction is truly allergic in nature. It should be recalled that other forms of allergy 
were well accepted as such many years before any antibody was ever demonstrated. 
Tuberculin allergy and contact allergy are excellent examples in point. It is only 
wflhin recent years by means of specialized cell transfer techniques that these forms 
of allergy have realized antibody demonstration. 
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In the axillary zirconium deodorant granulomas which are seen clinically, the 
possible route or routes of entry of the zirconium have caused much discussion. In 
women, in whom this disease has occurred predominantly, shaving of the axillary 
hair is such a common practice that it was regarded as an important factor in the 
development of this dermatosis. Indeed, in one of our experimental subjects in whom 
we produced the deodorant granulomas, the lesions could be clearly seen to develop 
in a linear shaving cut. However, they have also been observed beneath focal areas 
of miliaria. Actual streaming of microparticulate material through the miliarial vesicles 
and down into the dermis could be observed histologically. It is our feeling that any 
process, dermatitic or traumatic, which destroys the integrity of the epidermis or its 
impermeable barrier will allow for ready absorption of the essential granulomagenic 
substance, zirconium. Actually, in these hypersensitive individuals, it is likely that 
enough zirconium is absorbed through the major normal route of absorption, the 
pilosebaceous apparatus. 
Further consideration of the natural history of the zirconium deodorant granuloma 
as it relates to the allergic process is in order. The affected patients almost uniformly 
give a history of having used a zirconium-containing product for weeks to months 
prior to the appearance of their papular eruption. This, then, is the period in which 
the patients are non-allergic and will not react in this fashion to zirconium. In the 
latter part of this period they become sensitized to the zirconium. Once this sensitivity 
arises, residual or additional zirconium in the skin results in a delayed allergic granu-
loma formation. This latter phase, the development of the granuloma following ex-
posure to the zirconium in the sensitized individuals, represents the reaction time. For 
this form of allergy the reaction time is about two to three weeks for the development 
of a mature, fully-formed granuloma, although in more sensitive individuals, it may 
be shorter. In a few patients, the granulomatous reaction developed after what was 
believed to be the initial contact with zirconium. In these instances, which must be 
quite uncommon, we can assume that the patient had had prior exposure to zirconium, 
possibly as an inhalant, with prior sensitization. The concentration of zirconium in the 
deodorant sticks which will elicit the granulomatous response after topical application 
was shown to be 4% or above. However, it is possible that in more sensitive subjects 
one might expect even trace amounts of zirconium in any deodorant or other topical 
preparation to produce this response. We have no evidence as to the critical con-
centration necessary to induce sensitization to zirconium, but would feel that as with 
other forms of allergy, higher concentrations would more readily produce this effect. 
Treatment of the zircoruum deodorant granuloma has been generally disappointing. 
Systemic steroid therapy may produce temporary improvement and local injection of 
hydrocortisone may induce resolution of the lesions. This is quite in keeping with the 
allergic nature of the disorder. Topical treatment is ineffective in reducing or clearing 
the basic granulomatous process and is usually unnecessary for the management of any 
secondary acute inflammatory changes or pruritus since the latter are not prominent 
features of the condition. Cessation of zirconium deodorants and avoidance of all 
zirconium-containing products is necessary, of course, and eventually within 1-3 years 
the granulomatous lesions wifl involute spontaneously. It is quite probable that this 
clinical entity, the zirconium deodorant granuloma, wfll rarely be seen in the future 
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since zirconium has been removed from the market as a deodorant. However, indi-
viduals who have developed such sensitivity should be advised to avoid further contact 
with zirconium. This allergic sensitivity is not locaUzed to any area of the skin nor 
to the skin alone. It is generalized in nature and it is conceivable that a granulomatous 
"zirconiosis" of the lungs could ensue after inhalation of the element in industry or 
accidentally in dust in a given area of the country. Furthermore, it would seem 
judicious to re-examine the use of zirconium in surgical plates, intramedullary pins, 
sutures and the like in certain patients. 
In an earlier part of our study we learned that a granuloma develops when 
appreciable quantities of sodium stearate were introduced into the dermis. Initially we 
were convinced that this substance was responsible for the deodorant stick granulomas. 
However, we later came to realize that this was not the case, and that sodium stearate 
was producing a simple, non-allergic granuloma of the foreign-body type. In another 
paper we have recorded our findings with this non-aflergic granuloma". Sodium 
stearate is not responsible for the clinical axiflary granulomas seen since: (1) large 
quantities of sodium stearate are required to produuce the granulomatous response, 
(2) stearate granulomas resolve within a few weeks, (3) stearate will elicit granulomas 
regularly in every individual, and (4) patients with clinical deodorant granulomas 
show the normal response to stearate. However, the most spectacular distinction 
between the allergic and non-allergic granulomas relates to the quantity which one 
must inject in order to produce the two responses. In the zirconium granuloma, it 
is necessary to inject only a fraction of a microgram. With the stearate, in order to 
produce a comparable but non-allergic lesion, there must be a thousandfold increase 
in the quantity introduced. 
The zirconium deodorant granuloma is a prototype of the allergic granulomas 
seen in man. Histologically it is composed of nests of epithelioid cells, without central 
necrosis or caseation and with minimal associated inflammatory reaction. The develop-
ment of this pattern and its immutability for months to years, once its peak has been 
reached, are outstanding features of this type of granuloma. There is no piecemeal 
destruction of a central mass of insoluble or particulate matter as is seen in various 
foreign body granulomas. There is no palisading of the epithelioid cells peripherally 
about a central caseous or necrotic mass with an outside rim of monocytes as is seen 
in the tuberculoid granulomas such as tuberculosis, syphilis, and mycotic infections. 
There is simply gradual growth and transformation of reticulo-endothelial cefls into 
stable epithelioid cefls apparently as a result of antigen-antibody reaction. This is a 
focal process at first, perivascular in the main, but ultimately the picture is quite diffuse 
with replacement of most or all of the normal tissue. This type of granulomatous 
patterning has been referred to as "epithelioid" or "sarcoid" and is seen classically in 
such conditions as sarcoidosis and tuberculoid leprosy. It is not possible at this time to 
state that these diseases, which resemble the allergic zirconium deodorant granuloma 
histologically, are necessarfly totally allergic in nature themselves. However, with the 
knowledge that a simple chemical, zirconium, can of itself produce the diffuse, 
sarcoid-type granuloma as described herein, we should critically evaluate these and 
other granulomatous diseases with this possibility in mind. There is some evidence to 
indicate that both sarcoidosis and tuberculoid leprosy do represent allergic granulomas 
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in the strict sense. Support for such a view is found in the Kveim test, in which the 
intradermal injection of a 10% saline suspension of sarcoid tissue produces a granulo-
matous papule at three to five weeks in most cases of sarcoidosis. The allergen or 
granulomagenic material in the Kveim antigen has not yet been identified. Similarly, 
intradermal inoculation of a phenolized, ground-up suspension of lepra bacifli wfll 
produce, in patients with tuberculoid leprosy (but not in those with lepromatous 
leprosy), a granulomatous papule at three weeks. This reaction, known as the Mitsuda 
reaction, is an aid in the diagnosis of tuberculoid leprosy and indicates a hypersensitivity 
of these patients to some fraction of the mycobacteria. Beryllium and sflicon granulomas 
also may represent allergic granulomas and should be investigated from this standpoint. 
Intradermal testing with dflutions of beryllium or siflcon salts might well indicate that 
these patients have a hypersensitivity to these metals which could be responsible for 
their granulomas. 
It is not necessary to postulate an aflergic mechanism to explain the pathogenesis 
of foreign body granulomas since the process seems to be simply one of phagocytosis 
of the foreign material by the reticulo-endothelial cells. Extensive discussion of the 
possible importance of an allergic process in the development of the tuberculoid granu-
lomas is not within the scope of this paper. Patients with tuberculosis, deep fungous 
infections, syphilis, do have an associated allergic hypersensitivity, as indicated by a 
tuberculin-type (48 hours) response to skin test antigen preparations of the various 
organisms. However, this allergic response is not granulomatous in nature and, unlike 
the Kveim or Mitsuda reactions, does not necessarily indicate that a granulomatous 
stage of the disease is present. As exemplified by the Mantoux tuberculin test, a 
positive skin test merely indicates previous exposure and sensitization (with the tuber-
culin-type allergy) to the purified protein derivative of the tubercle bacillus. The 
pathogenesis of the tuberculoid granulomas does not seem to have been satisfactorily 
explained on the basis of secondary reaction to the organisms themselves, their products, 
or as a result of tissue destruction^". Its elucidation awaits further study. 
Summary 
A new dermatologic entity, the zirconium deodorant granuloma, has been 
described and experimental and clinical studies regarding its pathogenesis reviewed. 
It has been shown that the zirconium deodorant granuloma is the result of an allergic 
hyperesensflivity on the part of the affected individuals to the metal, zirconium, which 
manifests itself as a granuloma. This, to our knowledge, is the first demonstration in 
man, that an allergic processs can be responsible for the development of a granuloma. 
The significance of this new form of allergy in relation to other granulomatous dis-
orders in medicine is discussed. 
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